Detalle Publicación

Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial: a case-cohort study
Autores: Yu, E.; Papandreou, C.; Ruiz-Canela, Miguel; Guasch-Ferre, M.; Clish, C. B.; Dennis, C.; Liang, L. M.; Corella, D. ; Fito, M.; Razquin Burillo, Cristina; Lapetra, J.; Estruch, R.; Ros, E.; Cofan, M.; Aros, F.; Toledo Atucha, Estefanía; Serra-Majem, L.; Sorli, J. V.; Hu, F. B. ; Martínez González, Miguel Ángel; Salas-Salvado, J. (Autor de correspondencia)
Título de la revista: CLINICAL CHEMISTRY
ISSN: 0009-9147
Volumen: 64
Número: 8
Páginas: 1211 - 1220
Fecha de publicación: 2018
Lugar: WOS
BACKGROUND: Metabolites of the tryptophan-kynurenine pathway (i.e., tryptophan, kynurenine, kynurenic acid, quinolinic acid, 3-hydroxyanthranilic) may be associated with diabetes development. Using a case-cohort design nested in the Prevencion con Dieta Mediterranea (PREDIMED) study, we studied the associations of baseline and 1-year changes of these metabolites with incident type 2 diabetes (T2D). METHODS: Plasma metabolite concentrations were quantified via LC-MS for n = 641 in a randomly selected subcohort and 251 incident cases diagnosed during 3.8 years of median follow-up. Weighted Cox models adjusted for age, sex, body mass index, and other T2D risk factors were used. RESULTS: Baseline tryptophan was associated with higher risk of incident T2D (hazard ratio = 1.29; 95% CI, 1.04-1.61 per SD). Positive changes in quinolinic acid from baseline to 1 year were associated with a higher risk of T2D (hazard ratio = 1.39; 95% CI, 1.09-1.77 per SD). Baseline tryptophan and kynurenic acid were directly associated with changes in homeostatic model assessment for insulin resistance (HOMA-IR) from baseline to 1 year. Concurrent changes in kynurenine, quinolinic acid, 3-hydroxyanthranilic acid, and kynurenine/tryptophan ratio were associated with baseline-to-1-year changes in HOMA-IR. CONCLUSIONS: Baseline tryptophan and 1-year increases in quinolinic acid were positively associated with incident T2D. Baseline and 1-year changes in tryptophan metabolites predicted changes in HOMA-IR. Tryptophan levels may initially increase and then deplete as diabetes progresses in severity. (C) 2018 American Association for Clinical Chemistry